Director Michael Thaman awarded 558 Sherwin-Williams (SHW) RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
THAMAN MICHAEL H reported acquisition or exercise transactions in this Form 4 filing.
Sherwin-Williams director Michael H. Thaman reported an award of 558 restricted stock units, each representing one share of Common Stock, granted at $0 under the 2025 Equity and Incentive Compensation Plan. The RSUs vest in three annual installments starting on February 16, 2027. After this grant, he beneficially owns 8,111 shares and RSUs directly and 5,480.97 deferred stock units indirectly through the 2005 Director Deferred Fee Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
THAMAN MICHAEL H
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 558 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 8,111 shares (Direct);
Common Stock — 5,480.97 shares (Indirect, Deferred Fee Plan)
Footnotes (1)
- Grant of restricted stock units ("RSUs"), pursuant to the terms of an RSU agreement under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock. The RSUs vest annually in three substantially equal installments commencing February 16, 2027. These securities consist of 1,100 RSUs and 7,011 shares of Common Stock. No transaction is being reported on this line. Reported on a previously filed Form 4. These securities consist of deferred stock units, held pursuant to the 2005 Director Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.
FAQ
What insider transaction did Sherwin-Williams (SHW) director Michael H. Thaman report?
Michael H. Thaman reported receiving 558 restricted stock units in Sherwin-Williams Common Stock. The units were granted at a price of $0 under the company’s 2025 Equity and Incentive Compensation Plan and represent a stock-based compensation award, not an open-market purchase.
How many Sherwin-Williams (SHW) RSUs did Michael H. Thaman receive and when do they vest?
He received 558 restricted stock units, each equal to one Sherwin-Williams share. These RSUs vest in three substantially equal annual installments, with vesting commencing on February 16, 2027, according to the terms of the RSU agreement under the 2025 Equity and Incentive Compensation Plan.
What is the Sherwin-Williams (SHW) 2025 Equity and Incentive Compensation Plan mentioned in the filing?
The 2025 Equity and Incentive Compensation Plan is the program under which Thaman’s 558 restricted stock units were granted. Each RSU under this plan entitles the reporting person to receive one share of Sherwin-Williams Common Stock, subject to the plan’s vesting schedule and other terms.
What is the Sherwin-Williams (SHW) 2005 Director Deferred Fee Plan referenced in the Form 4?
The 2005 Director Deferred Fee Plan holds Thaman’s 5,480.97 deferred stock units. These units include those acquired through the plan’s dividend reinvestment feature, allowing director compensation and related amounts to be deferred into stock-based units rather than taken as immediate cash payments.
Does the Sherwin-Williams (SHW) Form 4 report any open-market stock purchases or sales?
The Form 4 reports a grant or award of 558 restricted stock units at $0, coded as an acquisition (A). Footnotes clarify the award is part of an equity compensation plan, and no open-market purchase or sale transaction is reported in this filing.